Influenza Viruses
Reference315 articles.
1. Abraham GM, Morton JB, Saravolatz LD. Baloxavir: a novel antiviral agent in the treatment of influenza. Clin Infect Dis. 2020;71:1790–4. 2. Ai J, Huang Y, Xu K, Ren D, Zi X, Ji H, Ge A, Dai Q, Li J, Bao C, Tang F, Shi G, Shen T, Zhu Y, Zhou M, Wang H. Case-control study of risk factors for human infection with influenza A(H7N9) virus in Jiangsu province, China, 2013. Euro Surveill. 2013;18:20510. 3. Alame MM, Massaad E, Zaraket H. Peramivir: a novel intravenous neuraminidase inhibitor for treatment of acute influenza infections. Front Microbiol. 2016;7:450. 4. Aledort JE, Lurie N, Wasserman J, Bozzette SA. Non-pharmaceutical public health interventions for pandemic influenza: an evaluation of the evidence base. BMC Public Health. 2007;7:208. 5. Alford RH, Kasel JA, Gerone PJ, Knight V. Human influenza resulting from aerosol inhalation. Procedings of the Society for Experimental Biology and Medicine. 1966;122:800–4.
|
|